Page last updated: 2024-08-21

diphenylamine and Parkinson Disease

diphenylamine has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berg, D; Brockmann, K; Burbulla, LF; Dhingra, A; Gasser, T; Glatza, M; Hargus, G; Heck, SA; Höing, S; Klewin, M; Klingauf, J; Kluba, T; Krüger, R; Kuhlmann, T; Maisel, M; Müller, H; Müller, S; Psathaki, OE; Reinhardt, P; Schmid, B; Schöler, HR; Schöndorf, DC; Sterneckert, J; Thiel, CS; Tsytsyura, Y; Wagner, L; Wu, G	1

Other Studies

1 other study(ies) available for diphenylamine and Parkinson Disease

Article	Year
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell stem cell, 2013, Mar-07, Volume: 12, Issue:3 Topics: Benzamides; Cell Differentiation; Cells, Cultured; Diphenylamine; Dopamine; Extracellular Signal-Regulated MAP Kinases; Humans; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Neurons; Oxidopamine; Parkinson Disease; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Rotenone	2013

Article

Year

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Cell stem cell, 2013, Mar-07, Volume: 12, Issue:3

Topics: Benzamides; Cell Differentiation; Cells, Cultured; Diphenylamine; Dopamine; Extracellular Signal-Regulated MAP Kinases; Humans; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Neurons; Oxidopamine; Parkinson Disease; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Rotenone

2013